<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39528408</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2448-5667</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>06</Day></PubDate></JournalIssue><Title>Revista medica del Instituto Mexicano del Seguro Social</Title><ISOAbbreviation>Rev Med Inst Mex Seguro Soc</ISOAbbreviation></Journal><ArticleTitle>[Rare diseases in a medical genetics service of population with social security].</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>8</EndPage><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5880</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5281/zenodo.10998859</ELocationID><ELocationID EIdType="pii" ValidYN="Y">E5880</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Rare diseases (RD) are those that have a low prevalence in the population; &#x2248;80% have a genetic origin, and to diagnose them it takes from 5 to 10 years, and they require evaluations from &#x2248;10 specialists. There is no international consensus on the definition and number of RDs, which affects the availability of resources for their diagnosis, treatment, and research.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To determine the prevalence of RDs in the Medical Genetics Service of a regional general hospital belonging to the Mexican Institute for Social Security (IMSS), in Puebla, Mexico.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">The patients' records who were evaluated by the above-mentioned service from January 2019 to June 2022 were reviewed. Those patients with a diagnosis of a RD were identified, and the prevalence was obtained by using the formula: total number of cases of the disease/number of people in the population at that moment in time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 798 medical records were reviewed and a prevalence of RDs of 27% was obtained. Those diseases with a prevalence of 1 case per 2000 inhabitants were considered, being 118 different RD. Considering only the 20 rare diseases registered in Mexico in 2022, 11 of these were detected, distributed in 35 patients, with an estimated prevalence of 4.3%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The prevalence of RDs differs according to the criteria implemented. In Mexico, several diseases that fall within the definition of a RD based on their prevalence were not considered as such until 2022, so the recent recognition of rare diseases included by the World Health Organization will benefit affected patients.</AbstractText><CopyrightInformation>Licencia CC 4.0 (BY-NC-ND) &#xa9; 2024 Revista M&#xe9;dica del Instituto Mexicano del Seguro Social.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jim&#xe9;nez-P&#xe9;rez</LastName><ForeName>Berenice</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1872-0685</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Gen&#xe9;tica M&#xe9;dica. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ju&#xe1;rez-Melchor</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9060-7241</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Gen&#xe9;tica M&#xe9;dica. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzm&#xe1;n-Santiago</LastName><ForeName>Ania Alejandra</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0001-7332-1735</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Gen&#xe9;tica M&#xe9;dica. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Ortega</LastName><ForeName>Azucena</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-7949-8005</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Gen&#xe9;tica M&#xe9;dica. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vera-Loaiza</LastName><ForeName>Aurea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7834-3404</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Gen&#xe9;tica M&#xe9;dica. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Mart&#xed;nez</LastName><ForeName>Cuauht&#xe9;moc</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3626-0704</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Servicio de Epidemiolog&#xed;a. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar-C&#xf3;zatl</LastName><ForeName>Israel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5184-0523</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Hospital General de Zona No. 20, Coordinaci&#xf3;n Cl&#xed;nica de Educaci&#xf3;n e Investigaci&#xf3;n en Salud. Puebla, Puebla, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Enfermedades raras en un servicio de gen&#xe9;tica m&#xe9;dica de poblaci&#xf3;n con seguridad social.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Rev Med Inst Mex Seguro Soc</MedlineTA><NlmUniqueID>101243727</NlmUniqueID><ISSNLinking>0443-5117</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035583" MajorTopicYN="Y">Rare Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012943" MajorTopicYN="Y">Social Security</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005826" MajorTopicYN="N">Genetics, Medical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006769" MajorTopicYN="N">Hospitals, General</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">son enfermedades raras (ER) aquellas con baja prevalencia en la poblaci&#xf3;n; &#x2248;80% tienen un origen gen&#xe9;tico, y para su diagn&#xf3;stico pasan de 5 a 10 a&#xf1;os y se requieren valoraciones de &#x2248;10 especialistas. No hay un consenso internacional sobre la definici&#xf3;n y el n&#xfa;mero de ER, lo que afecta la disponibilidad de recursos para su diagn&#xf3;stico, tratamiento e investigaci&#xf3;n.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">determinar la prevalencia de las ER en el Servicio de Gen&#xe9;tica M&#xe9;dica de un hospital general de zona del Instituto Mexicano del Seguro Social (IMSS), en Puebla, M&#xe9;xico.</AbstractText><AbstractText Label="MATERIAL Y M&#xc9;TODOS" NlmCategory="UNASSIGNED">se revisaron los expedientes de los pacientes valorados por el servicio mencionado de enero de 2019 a junio de 2022. Se identificaron los pacientes con diagn&#xf3;stico de alguna ER, y se obtuvo la prevalencia mediante la f&#xf3;rmula: n&#xfa;mero total de casos de la enfermedad/n&#xfa;mero de personas en la poblaci&#xf3;n en ese momento del tiempo.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">se revisaron un total de 798 expedientes y se obtuvo una prevalencia de ER del 27%. Se consideraron aquellas enfermedades con una prevalencia de un caso por cada 2000 habitantes, con 118 ER diferentes. Considerando solo las 20 ER registradas en M&#xe9;xico en el 2022, se detectaron 11 de estas, distribuidas en 35 pacientes, con una prevalencia de 4.3%.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N" NlmCategory="UNASSIGNED">la prevalencia de ER difiere seg&#xfa;n los criterios empleados. En M&#xe9;xico, muchas enfermedades que cumplen con la definici&#xf3;n de ER con base en su prevalencia no eran consideradas como tales hasta el 2022, por lo que el reciente reconocimiento de las ER incluidas por la Organizaci&#xf3;n Mundial de la Salud beneficiar&#xe1; a los pacientes afectados.</AbstractText><CopyrightInformation>Licencia CC 4.0 (BY-NC-ND) &#xa9; 2024 Revista M&#xe9;dica del Instituto Mexicano del Seguro Social.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Orphan Drug</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Rare Diseases</Keyword></KeywordList><CoiStatement>los autores han completado y enviado la forma traducida al espa&#xf1;ol de la declaraci&#xf3;n de conflictos potenciales de inter&#xe9;s del Comit&#xe9; Internacional de Editores de Revistas M&#xe9;dicas, y no fue reportado alguno que tuviera relaci&#xf3;n con este art&#xed;culo.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>14</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>14</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>11</Day><Hour>22</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39528408</ArticleId><ArticleId IdType="pmc">PMC12212923</ArticleId><ArticleId IdType="doi">10.5281/zenodo.10998859</ArticleId><ArticleId IdType="pii">E5880</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carbajal-Rodr&#xed;guez L. Enfermedades raras. Revista Mexicana de Pediatr&#xed;a. 2015;82(6):207&#x2013;210.</Citation></Reference><Reference><Citation>Comisi&#xf3;n para el An&#xe1;lisis, Evaluaci&#xf3;n, Registro y Seguimiento de las Enfermedades Raras. Reglamento Interior de la Comisi&#xf3;n para el An&#xe1;lisis, Evaluaci&#xf3;n, Registro y Seguimiento de las Enfermedades Raras. Diario Oficial de la Federaci&#xf3;n; M&#xe9;xico: 2017. pp. 1&#x2013;6.</Citation></Reference><Reference><Citation>Carbajal Rodr&#xed;guez L, Navarrete Mart&#xed;nez JI. Enfermedades raras. Acta Pediatr Mex. 2015;36:369&#x2013;373.</Citation></Reference><Reference><Citation>Mej&#xed;a V&#xe1;zquez R, Salgado Schoelly H, Delgado Cruz FT.  Medicamentos hu&#xe9;rfanos y enfermedades raras. Secretar&#xed;a de Salud de la ciudad de M&#xe9;xico; Ciudad de M&#xe9;xico: 2020.  Disponible en: https://salud.cdmx.gob.mx/storage/app/media/2018-2024/medicamentos/boletines2020/Boletin1feb2020.pdf .</Citation></Reference><Reference><Citation>Consejo de Salubridad General. Lista actualizada de las enfermedades que se han determinado como raras en M&#xe9;xico 2018. Consejo de Salubridad General; M&#xe9;xico: 2018. p. 12. Disponible en: http://www.csg.gob.mx/descargas/pdf/priorizacion/enfermedades-raras/Listado/Lista_Enfermedades_Raras_2018.pdf .</Citation></Reference><Reference><Citation>Consejo de Salubridad General. Ampl&#xed;a Consejo de Salubridad General lista de enfermedades raras. Consejo de Salubridad General; M&#xe9;xico: 2023.  Disponible en: http://csg.gob.mx/descargas/pdf/comunicados/CSG_Comunicado_N._2_26may23.pdf .</Citation></Reference><Reference><Citation>Consejo de Salubridad General. Acuerdo por el que se reconocen las enfermedades raras incorporadas en la Clasificaci&#xf3;n Internacional de Enfermedades emitida por la Organizaci&#xf3;n Mundial de la Salud. Diario Oficial de la Federaci&#xf3;n; M&#xe9;xico: 2023.  Disponible en: https://dof.gob.mx/nota_detalle.php?codigo=5693770&amp;fecha=29/06/2023#gsc.tab=0 .</Citation></Reference><Reference><Citation>Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. European Journal of Human Genetics. 2020;28(2):165&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6974615</ArticleId><ArticleId IdType="pubmed">31527858</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel M, Vasilevsky N, Unni D, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7771654</ArticleId><ArticleId IdType="pubmed">32020066</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xf6;ster TS, von Wyl V, Beeler PE, et al. Frequency-based rare diagnoses as a novel and accessible approach for studying rare diseases in large datasets: a cross-sectional study. BMC Med Res Methodol. 2023;23(1):143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10276905</ArticleId><ArticleId IdType="pubmed">37330464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira CR. The burden of rare diseases. Am J Med Genet A. 2019;179(6):885&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TSJ, Chopra M, Kim RH, et al.  Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis. Orphanet J Rare Dis. 2023;18(1):292. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02911-2 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10500831</ArticleId><ArticleId IdType="pubmed">37710322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hageman IC, van Rooij IALM, de Blaauw I, et al.  A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance. Orphanet J Rare Dis. 2023;18(1):106. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02719-0 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10163740</ArticleId><ArticleId IdType="pubmed">37147718</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzucato M, Pozza LVD, Facchin P, et al.  ORPHAcodes use for the coding of rare diseases: comparison of the accuracy and cross country comparability. Orphanet J Rare Dis. 2023;18(1):267. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02864-6 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10476382</ArticleId><ArticleId IdType="pubmed">37667299</ArticleId></ArticleIdList></Reference><Reference><Citation>Willmen T, Willmen L, Pankow A, et al.  Rare diseases: why is a rapid referral to an expert center so important? BMC Health Serv Res. 2023;23(1):904. Disponible en: https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-023-09886-7 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10463573</ArticleId><ArticleId IdType="pubmed">37612679</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer E, Millis N, Farrar M, et al. Rare diseases: New approaches to diagnosis and care. Med Today. 2023;24(1-2):69&#x2013;75.</Citation></Reference><Reference><Citation>Faviez C, Chen X, Garcelon N, et al.  Diagnosis support systems for rare diseases: a scoping review. Orphanet J Rare Dis. 2020;15(1):94. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01374-z .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164220</ArticleId><ArticleId IdType="pubmed">32299466</ArticleId></ArticleIdList></Reference><Reference><Citation>Marimpietri D, Zuccari G. Development of Medicines for Rare Pediatric Diseases. Pharmaceuticals. 2023;16(4):513. Disponible en: https://www.mdpi.com/1424-8247/16/4/513 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10143853</ArticleId><ArticleId IdType="pubmed">37111269</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasemann C, H&#xf6;ppner J, Burgard P, et al.  Transition for adolescents with a rare disease: results of a nationwide German project. Orphanet J Rare Dis. 2023;18(1):93. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02698-2 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10131406</ArticleId><ArticleId IdType="pubmed">37098531</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews L, Chin V, Taliangis M, et al.  Childhood rare diseases and the UN convention on the rights of the child. Orphanet J Rare Dis. 2021;16(1):523. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-021-02153-0 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709987</ArticleId><ArticleId IdType="pubmed">34952617</ArticleId></ArticleIdList></Reference><Reference><Citation>Velvin G, Dammann B, Haagensen T, et al.  Work participation in adults with rare genetic diseases - a scoping review. BMC Public Health. 2023;23(1):910. Disponible en: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15654-3 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10197424</ArticleId><ArticleId IdType="pubmed">37208707</ArticleId></ArticleIdList></Reference><Reference><Citation>Larizza L, Cubellis MV. Rare Diseases: Implementation of Molecular Diagnosis, Pathogenesis Insights and Precision Medicine Treatment. Int J Mol Sci. 2023;24(10):9064. Disponible en: https://www.mdpi.com/1422-0067/24/10/9064 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219232</ArticleId><ArticleId IdType="pubmed">37240412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright CF, Fitzpatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19(5):253&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">29398702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Silva G, Trevi&#xf1;o-de la Fuente F, Trevi&#xf1;o-Alanis MG. Enfermedades raras en M&#xe9;xico. Rev Med Inst Mex Seguro Soc. 2018;56(3):214&#x2013;215. Disponible en: https://www.redalyc.org/journal/4577/457757174002/ </Citation><ArticleIdList><ArticleId IdType="pubmed">30365280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurca-Simina IE, Chirita-Emandi A, Andreescu N, et al. Burden Of Rare Genetic Diseases-Experience Of Timis Regional Centre Of Medical Genetics, Romania. Jurnalul Pediatrului-Year XXII. 2019;22:85&#x2013;86.</Citation></Reference><Reference><Citation>Tumiene B, Peters H, Melegh B, et al.  Rare disease education in Europe and beyond: time to act. Orphanet J Rare Dis. 2022;17(1):441. Disponible en: https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02527-y .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9761619</ArticleId><ArticleId IdType="pubmed">36536417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitsani P, Katsaras G, Soteriades ES. Barriers to and Facilitators of Providing Care for Adolescents Suffering from Rare Diseases: A Mixed Systematic Review. Pediatr Rep. 2023;15(3):462&#x2013;482. Disponible en: https://www.mdpi.com/2036-7503/15/3/43 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10443320</ArticleId><ArticleId IdType="pubmed">37606447</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35438918</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1606-7916</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Salud publica de Mexico</Title><ISOAbbreviation>Salud Publica Mex</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>229</EndPage><MedlinePgn>225-229</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21149/13679</ELocationID><Abstract><AbstractText>La creciente epidemia de obesidad ha sido uno de los retos m&#xe1;s importantes de salud p&#xfa;blica en M&#xe9;xico durante los &#xfa;ltimos a&#xf1;os. Con apoyo de la Federaci&#xf3;n Mundial de Obesidad, en 2021 formamos un grupo de profesionales para identificar y resumir las acciones prioritarias en las que puede enfocarse nuestro pa&#xed;s para hacer frente a esta epidemia. Al proceso de desarrollo y discusi&#xf3;n de este grupo se sumaron m&#xe1;s de 1 000 profesionales de la salud para retomar recomendaciones de documentos y gu&#xed;as de alto nivel previamente publicados. En conmemoraci&#xf3;n del D&#xed;a Mundial de la Obesidad, en este 2022 se presenta esta postura como insumo para el desarrollo de acciones en el &#xe1;mbito profesional y de los diferentes sectores, en la que se incluyen 10 recomendaciones de acci&#xf3;n, desde la perspectiva poblacional hasta la atenci&#xf3;n individualizada, y se enfatiza en la importancia de la participaci&#xf3;n social, de las intervenciones integrales con visi&#xf3;n centrada en la persona y de la sostenibilidad planetaria, adem&#xe1;s de mejorar la educaci&#xf3;n y las campa&#xf1;as de difusi&#xf3;n, propiciar un ambiente promotor de entornos activos y blindar de conflictos de inter&#xe9;s los esfuerzos de prevenci&#xf3;n y control. La postura hace un llamado para abordar la obesidad de manera seria, con base en la evidencia cient&#xed;fica, oportuna e integral, con enfoque de curso de vida, de forma &#xe9;tica y sensible, y sin perpetuar las barreras del estigma de peso en la sociedad.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barquera</LastName><ForeName>Sim&#xf3;n</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. sbarquera@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe9;jar-Renter&#xed;a</LastName><ForeName>Lesly Samara</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. investigador21@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar-Salinas</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n. Ciudad de M&#xe9;xico, M&#xe9;xico.. caguilarsalinas@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garibay-Nieto</LastName><ForeName>Nayely</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico Dr. Eduardo Liceaga. Ciudad de M&#xe9;xico, M&#xe9;xico. gngaribay@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Garc&#xed;a</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n. Ciudad de M&#xe9;xico, M&#xe9;xico. caosjegg@aol.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bovecchio</LastName><ForeName>Anabelle</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. bonvecchio@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perichart</LastName><ForeName>Otilia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Perinatolog&#xed;a Isidro Espinosa de los Reyes. Ciudad de M&#xe9;xico, M&#xe9;xico. oti_perichart@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Tamayo</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Cardiolog&#xed;a Ignacio Ch&#xe1;vez. Ciudad de M&#xe9;xico, M&#xe9;xico. margaritatorrestamayo@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esquivias-Zavala</LastName><ForeName>H&#xe9;ctor</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Psiquiatr&#xed;a Ram&#xf3;n de la Fuente Mu&#xf1;iz. Ciudad de M&#xe9;xico, M&#xe9;xico. doctoresquivias@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villalpando-Carri&#xf3;n</LastName><ForeName>Salvador</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Infantil de M&#xe9;xico Federico G&#xf3;mez. Ciudad de M&#xe9;xico, M&#xe9;xico. villalpandoca@himfg.edu.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-M&#xe9;ndez</LastName><ForeName>Rosalba Carolina</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Unidad M&#xe9;dica de Alta Especialidad, Hospital de Cardiolog&#xed;a, Centro M&#xe9;dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de M&#xe9;xico, M&#xe9;xico. carolgmmx@yahoo.com.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apolinar-Jim&#xe9;nez</LastName><ForeName>Evelia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Regional de Alta Especialidad del Baj&#xed;o Hospital Regional de Alta Especialidad del Baj&#xed;o, Le&#xf3;n, Guanajuato, M&#xe9;xico. eve.apolinar@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufer-Horwitz</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Ciudad de M&#xe9;xico, M&#xe9;xico. marthakaufer@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Monta&#xf1;ez</LastName><ForeName>Olga Georgina</ForeName><Initials>OG</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n de Prestaciones Econ&#xf3;micas y Sociales, Instituto Mexicano del Seguro Social (IMSS), M&#xe9;xico. georgina.martinezm@imss.gob.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fajardo Niquete</LastName><ForeName>Ileana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n de Nutrici&#xf3;n y Enfermedades Cr&#xf3;nicas de los Servicios de Salud de Yucat&#xe1;n, M&#xe9;rida, M&#xe9;xico. Ileana.fajardo@ssy.gob.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguirre Crespo</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n General de los Servicios Estatales de Salud, Secretar&#xed;a de Salud, Canc&#xfa;n, Quintana Roo, M&#xe9;xico. alas_jungla@icloud.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-&#xc1;lvarez</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Jefatura del Servicio de Cardiolog&#xed;a, Centro M&#xe9;dico Nacional 20 de Noviembre del ISSSTE, Ciudad de M&#xe9;xico, M&#xe9;xico. egomezal@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Jim&#xe9;nez</LastName><ForeName>Sergio C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Ciudad de M&#xe9;xico, M&#xe9;xico. sergio.hernandezj@incmnsz.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denova-Guti&#xe9;rrez</LastName><ForeName>Edgar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>) Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. edgar.denova@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batis</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. carolina.batis@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El&#xed;as-L&#xf3;pez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Ciudad de M&#xe9;xico, M&#xe9;xico. drdanielelias@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palos-Lucio</LastName><ForeName>Ana Gabriela</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Facultad de Enfermer&#xed;a y Nutrici&#xf3;n, Universidad Aut&#xf3;noma de San Luis Potos&#xed;, San Luis Potos&#xed;, M&#xe9;xico. gapalux@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;squez Garibay</LastName><ForeName>Edgar M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Instituto de Nutrici&#xf3;n Humana, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, M&#xe9;xico. vasquez.garibay@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Velarde</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Pediatr&#xed;a del Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" . enrique.romerovelarde@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Rodr&#xed;guez</LastName><ForeName>Mar&#xed;a Araceli</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Facultad de Nutrici&#xf3;n, Universidad Aut&#xf3;noma del Estado de Morelos, M&#xe9;xico. araceli.ortiz@uaem.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almendra-Pegueros</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidad Cuauht&#xe9;moc, San Luis Potos&#xed;, M&#xe9;xico. ralmendrap@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contreras</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. alejandra.contreras@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. claunietorozc@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Cordero</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones para el Desarrollo con Equidad (EQUIDE), Universidad Iberoamericana, Ciudad de M&#xe9;xico, M&#xe9;xico. sonia.hernandez@ibero.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mungu&#xed;a</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. anamunguia200788@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Russell</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Zaragoza, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, M&#xe9;xico. mr1811@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Escobedo</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universidad Vizcaya de las Am&#xe9;ricas, Yucat&#xe1;n, M&#xe9;xico. saam.sanchez@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Am&#xe9;zquita</LastName><ForeName>Elvia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universidad Modelo, Yucat&#xe1;n, M&#xe9;xico. maggy@modelo.edu.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aranda-Gonz&#xe1;lez</LastName><ForeName>Irma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Aut&#xf3;noma de Yucat&#xe1;n, Yucat&#xe1;n, M&#xe9;xico. irma.aranda@correo.uady.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz-Casarrubias</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. casarrubiasnt@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos-Nonato</LastName><ForeName>Ismael</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. icampos@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Espino</LastName><ForeName>F&#xe1;tima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universidad Aut&#xf3;noma del Estado de M&#xe9;xico, Estado de M&#xe9;xico, M&#xe9;xico. fatimage@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-V&#xe1;zquez</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Ciudad de M&#xe9;xico, M&#xe9;xico. soph_mtz@yahoo.com.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arellano-G&#xf3;mez</LastName><ForeName>Laura P</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Departamento de Psicolog&#xed;a, Educaci&#xf3;n y Salud, Instituto Tecnol&#xf3;gico y de Estudios Superiores de Occidente (ITESO), Tlaquepaque, Jalisco, M&#xe9;xico. larellano@iteso.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caballero-Cant&#xfa;</LastName><ForeName>Idalia</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Universidad de Monterrey, Nuevo Le&#xf3;n, M&#xe9;xico. idalia.caballero@udem.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunot Alexande</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto de Nutrici&#xf3;n Humana, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, M&#xe9;xico. claudia.hunot@academicos.udg.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valero-Morales</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. iisabel.valero@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Gonz&#xe1;lez</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universidad Aut&#xf3;noma de Aguascalientes, M&#xe9;xico. anerolgonzalez@yahoo.com.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xed;os-Cort&#xe1;zar</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universidad Aut&#xf3;noma Metropolitana - Xochimilco, Ciudad de M&#xe9;xico, M&#xe9;xico. vrios@correo.xoc.uam.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Garc&#xed;a</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. catalina.medina@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argumedo</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. investigador19@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calleja Enr&#xed;quez</LastName><ForeName>Carmen Rosa</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Hospital &#xc1;ngeles, Tijuana Baja California, M&#xe9;xico. calleja.md@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles Mac&#xed;as</LastName><ForeName>Edna</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital General Regional 1, Instituto Mexicano del Seguro Social, Tijuana BC, M&#xe9;xico. ednarobles1@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nava-Gonz&#xe1;lez</LastName><ForeName>Edna J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Facultad de Salud P&#xfa;blica y Nutrici&#xf3;n, Universidad Aut&#xf3;noma de Nuevo Le&#xf3;n, Monterrey, M&#xe9;xico. ednajnava@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara-Riegos</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratorio de Bioqu&#xed;mica y Gen&#xe9;tica Molecular, Facultad de Qu&#xed;mica, Universidad Aut&#xf3;noma de Yucat&#xe1;n, M&#xe9;xico. julio.lara@correo.uady.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Plascencia</LastName><ForeName>Ana K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Cancerolog&#xed;a, Ciudad de M&#xe9;xico, M&#xe9;xico. anaksp@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Fern&#xe1;ndez</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto de Investigaciones para el Desarrollo con Equidad (EQUIDE), Universidad Iberoamericana, Ciudad de M&#xe9;xico, M&#xe9;xico. mauricio.hernandez@ibero.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Nu&#xf1;ez</LastName><ForeName>Jose Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Cl&#xed;nicas Integrales de Des&#xf3;rdenes Metab&#xf3;licos, Secretar&#xed;a de Salud, Coahuila de Zaragoza, M&#xe9;xico. joseluis@rodzmed.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangel-Quillo</LastName><ForeName>Sarai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universidad Aut&#xf3;noma de Quer&#xe9;taro, M&#xe9;xico. sarai.rangel@uaq.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cancino-Marentes</LastName><ForeName>Martha Edith</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Unidad Acad&#xe9;mica de Medicina, Universidad Aut&#xf3;noma de Nayarit, M&#xe9;xico. mecancino@uan.edu.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Viana</LastName><ForeName>M&#xf3;nica J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Subdirecci&#xf3;n de Prevenci&#xf3;n y Protecci&#xf3;n a la Salud, ISSSTE, M&#xe9;xico. monica.viana@issste.gob.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saldivar-Frausto</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad Acad&#xe9;mica de Desarrollo y Gesti&#xf3;n P&#xfa;blica, Universidad Aut&#xf3;noma de Zacatecas (UADGP-UAZ), M&#xe9;xico. saldivarsan@live.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-Ramirez</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universidad Vasco de Quiroga, Morelia Mich, M&#xe9;xico. malvarez.nutricion@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandoval-Salazar</LastName><ForeName>Cuauht&#xe9;moc</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de Enfermer&#xed;a y Obstetricia, Divisi&#xf3;n de Ciencias de Salud e Ingenier&#xed;as, Campus Celaya-Salvatierra, Universidad de Guanajuato, M&#xe9;xico. cuauhtemoc.sandoval@ugto.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Tinoco</LastName><ForeName>Rub&#xe9;n Oswaldo</ForeName><Initials>RO</Initials><AffiliationInfo><Affiliation>Cl&#xed;nica Especializada en el Manejo de la Diabetes de la Ciudad de M&#xe9;xico, M&#xe9;xico. ruben_ost@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Villanueva</LastName><ForeName>Mildred</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Escuela Superior de Ingenier&#xed;a y Arquitectura, Instituto Polit&#xe9;cnico Nacional, Ciudad de M&#xe9;xico, M&#xe9;xico. milamovi@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villarreal-Arce</LastName><ForeName>Maria Elena</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Universidad de Monterrey, Nuevo Le&#xf3;n, M&#xe9;xico. elena_arce@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barriguete</LastName><ForeName>J Armando</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n General de Pol&#xed;tica Educativa, Mejores Pr&#xe1;cticas y Cooperaci&#xf3;n Secretar&#xed;a de Educaci&#xf3;n P&#xfa;blica, Ciudad de M&#xe9;xico, M&#xe9;xico. barriguete@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Mariel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. marielswhite@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jauregui</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. alejandra.jauregui@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolentino-Mayo</LastName><ForeName>Lizbeth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. mltolentino@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Ridaura</LastName><ForeName>Ruy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE), Secretar&#xed;a de Salud, M&#xe9;xico. ruy.lopez@salud.gob.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera-Dommarco</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. jrivera@insp.mx.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Volvi&#xe9;ndonos mejores: necesidad de acci&#xf3;n inmediata ante el reto de la obesidad. Una postura de profesionales de la salud.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Salud Publica Mex</MedlineTA><NlmUniqueID>0404371</NlmUniqueID><ISSNLinking>0036-3634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>15</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35438918</ArticleId><ArticleId IdType="doi">10.21149/13679</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33191196</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2530-0180</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Endocrinologia, diabetes y nutricion</Title><ISOAbbreviation>Endocrinol Diabetes Nutr (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Familial non medullary thyroid carcinoma: Beyond the syndromic forms.</ArticleTitle><Pagination><StartPage>260</StartPage><EndPage>269</EndPage><MedlinePgn>260-269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.endinu.2020.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2530-0164(20)30216-0</ELocationID><Abstract><AbstractText>Familial non-medullary thyroid cancer is defined as the presence of non-medullary thyroid cancer in two or more first-degree relatives, in the absence of other predisposing factors. It represents up to 9% of differentiated thyroid cancers, and only a minority appears in well-known hereditary syndromes that associate thyroid cancer among many other clinical manifestations. However, in more than 95% of cases, thyroid cancer appears isolated, and its genetic causes have yet to be elucidated. We review here the current knowledge of the genetic basis of this pathology, as well as its clinical characteristics. Understanding the genetic mechanisms implied would help to comprehend the metabolic pathways involved, with the consequent potential therapeutic application. In addition, it would allow genetic counseling and to focus our efforts on patients at risk of developing this disorder.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 SEEN y SED. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orois</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitari M&#xfa;tua de Terrassa, Terrassa, Barcelona, Espa&#xf1;a; Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, ICMDM, Hospital Cl&#xed;nic de Barcelona, Barcelona, Espa&#xf1;a. Electronic address: aorois@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, ICMDM, Hospital Cl&#xed;nic de Barcelona, Barcelona, Espa&#xf1;a; Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Espa&#xf1;a; Facultad de Medicina, Universidad de Barcelona, Barcelona, Espa&#xf1;a; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Diabetes y Enfermedades Metab&#xf3;licas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halperin</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, ICMDM, Hospital Cl&#xed;nic de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriola</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Barcelona, Espa&#xf1;a; Facultad de Medicina, Universidad de Barcelona, Barcelona, Espa&#xf1;a; Servicio de Bioqu&#xed;mica y Gen&#xe9;tica Molecular, CDB, Hospital Cl&#xed;nic de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Carcinoma diferenciado de tiroides familiar: m&#xe1;s all&#xe1; de las formas sindr&#xf3;micas.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Endocrinol Diabetes Nutr (Engl Ed)</MedlineTA><NlmUniqueID>101717565</NlmUniqueID><ISSNLinking>2530-0180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C&#xe1;ncer de tiroides</Keyword><Keyword MajorTopicYN="N">Familial</Keyword><Keyword MajorTopicYN="N">Familiar</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Gen&#xe9;tica</Keyword><Keyword MajorTopicYN="N">Germline mutations</Keyword><Keyword MajorTopicYN="N">Mutaciones germinales</Keyword><Keyword MajorTopicYN="N">No medular</Keyword><Keyword MajorTopicYN="N">Non-medullary</Keyword><Keyword MajorTopicYN="N">Thyroid cancer</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>16</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33191196</ArticleId><ArticleId IdType="doi">10.1016/j.endinu.2020.08.002</ArticleId><ArticleId IdType="pii">S2530-0164(20)30216-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30250332</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1146</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>5</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Boletin medico del Hospital Infantil de Mexico</Title><ISOAbbreviation>Bol Med Hosp Infant Mex</ISOAbbreviation></Journal><ArticleTitle>[Colestasis por deficiencia de 3b-&#x394;5-C27-hidroxiesteroide deshidrogenasa en un paciente con alteraci&#xf3;n en la s&#xed;ntesis de &#xe1;cidos biliares].</ArticleTitle><Pagination><StartPage>313</StartPage><EndPage>318</EndPage><MedlinePgn>313-318</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/BMHIM.18000008</ELocationID><Abstract><AbstractText Label="INTRODUCCI&#xd3;N">Los errores innatos en la s&#xed;ntesis de &#xe1;cidos biliares son un grupo de defectos gen&#xe9;ticos que representan del 1 al 2% de las enfermedades colest&#xe1;sicas cr&#xf3;nicas en lactantes, ni&#xf1;os y adolescentes. La deficiencia de 3b-&#x394;5-C27-hidroxiesteroide oxidoreductasa (3b-HSDH) es el defecto m&#xe1;s com&#xfa;nmente reportado. El cuadro cl&#xed;nico caracter&#xed;stico consiste en hepatitis neonatal, hepatomegalia, esplenomegalia, malabsorci&#xf3;n, desnutrici&#xf3;n y enfermedad hep&#xe1;tica de aparici&#xf3;n tard&#xed;a.</AbstractText><AbstractText Label="CASO CL&#xcd;NICO">Lactante masculino con antecedente de ictericia en escleras a los 4 meses que se resolvi&#xf3; espont&#xe1;neamente; posteriormente, a los 18 meses, present&#xf3; enfermedad colest&#xe1;sica. Durante su abordaje se document&#xf3; gamma-glutamil transpeptidasa normal, hallazgo que es altamente sugestivo de alteraci&#xf3;n en la s&#xed;ntesis de &#xe1;cidos biliares. El diagn&#xf3;stico se realiz&#xf3; con espectrometr&#xed;a de masas en orina. Se inici&#xf3; tratamiento con &#xe1;cido c&#xf3;lico oral, y present&#xf3; mejor&#xed;a inmediata.</AbstractText><AbstractText Label="CONCLUSIONES">El resultado en los &#xe1;cidos biliares urinarios es definitivo para el defecto gen&#xe9;tico y consistente con mutaciones homocigotas en el gen HSD3B7. Este padecimiento constituye un diagn&#xf3;stico de exclusi&#xf3;n en las enfermedades colest&#xe1;sicas de la infancia, particularmente el hallazgo de gamma-glutamil transpeptidasa normal o levemente aumentada, y responde adecuadamente al tratamiento oral, por lo que debe identificarse de forma temprana.</AbstractText><AbstractText Label="BACKGROUND">Inborn errors in bile acid synthesis are a group of genetic defects accounting for 1 to 2% of chronic cholestatic diseases in infants, children and adolescents. Deficiency of 3b-&#x394;5-C27-hydroxysteroid dehydrogenase (3&#x3b2;-HSDH) is the most common defect in this disease. Clinical features consist of neonatal hepatitis, hepatomegaly, splenomegaly, malabsorption, malnutrition, and late-onset liver disease.</AbstractText><AbstractText Label="CASE REPORT">A male infant who presented jaundice in sclera at 4 months that resolved spontaneously, later presented cholestatic disease at 18 months. During his approach, normal gamma-glutamyl transpeptidase was documented, a finding that is highly suggestive of alteration in the synthesis of bile acids. The diagnosis was made using urine mass spectrometry. Oral colic acid treatment was started, presenting immediate improvement.</AbstractText><AbstractText Label="CONCLUSIONS">The result in urinary bile acids is definitive for the genetic defect and consistent with homozygous mutations in the HSD3B7 gene. This condition is a diagnosis of exclusion in childhood cholestatic diseases, particularly in the presence of normal or mildly enlarged gamma-glutamyl transpeptidase, and responds adequately to oral treatment; it should be identified early.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2018 Secretar&#xcd;a de Salud.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almanza-Miranda</LastName><ForeName>Enory</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Gastroenterolog&#xed;a y Nutrici&#xf3;n Pedi&#xe1;trica, Centro M&#xe9;dico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE). Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pi&#xf1;a-Aguilar</LastName><ForeName>Ra&#xfa;l E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Servicio de Gen&#xe9;tica M&#xe9;dica, Centro M&#xe9;dico Nacional 20 de Noviembre, ISSSTE. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordo&#xf1;ez-Guti&#xe9;rrez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna Pedi&#xe1;trica, Centro M&#xe9;dico Nacional 20 de Noviembre, ISSSTE. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>M&#xaa; Teresa Gorraez-de la</ForeName><Initials>MTG</Initials><AffiliationInfo><Affiliation>Servicio de Patolog&#xed;a, Centro M&#xe9;dico Nacional 20 de Noviembre, ISSSTE. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a-V&#xe9;lez</LastName><ForeName>Rub&#xe9;n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna Pedi&#xe1;trica, Centro M&#xe9;dico Nacional 20 de Noviembre, ISSSTE. Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM). Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Cholestasis due to deficiency of 3b-&#x394;5-C27-hydroxysteroid dehydrogenase in a patient with altered bile acid synthesis.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Bol Med Hosp Infant Mex</MedlineTA><NlmUniqueID>0414106</NlmUniqueID><ISSNLinking>0539-6115</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001647">Bile Acids and Salts</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.-</RegistryNumber><NameOfSubstance UI="D015096">3-Hydroxysteroid Dehydrogenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.-</RegistryNumber><NameOfSubstance UI="C066485">3 beta-hydroxy-delta 5-C(27)-steroid dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>G1JO7801AE</RegistryNumber><NameOfSubstance UI="D019826">Cholic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015096" MajorTopicYN="N">3-Hydroxysteroid Dehydrogenases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001647" MajorTopicYN="N">Bile Acids and Salts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002779" MajorTopicYN="N">Cholestasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019826" MajorTopicYN="N">Cholic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007565" MajorTopicYN="N">Jaundice</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008661" MajorTopicYN="N">Metabolism, Inborn Errors</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bile acids</Keyword><Keyword MajorTopicYN="N">Cholestatic diseases</Keyword><Keyword MajorTopicYN="N">Chronic liver disease</Keyword><Keyword MajorTopicYN="N">Enfermedad hep&#xe1;tica cr&#xf3;nica</Keyword><Keyword MajorTopicYN="N">Enfermedades colest&#xe1;sicas</Keyword><Keyword MajorTopicYN="N">&#xc1;cidos biliares</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30250332</ArticleId><ArticleId IdType="doi">10.24875/BMHIM.18000008</ArticleId><ArticleId IdType="pii">j75/5/313</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>